Prevention of peritonitis in peritoneal dialysis

Seminars in Dialysis

Volumn 26, Issue 4, 2013, Pages 494-502

  Segal, Jonathan H ^a   Messana, Joseph M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; GENTAMICIN; PSEUDOMONIC ACID;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; CATHETER INFECTION; FEMALE; FUNGEMIA; HUMAN; MALE; METHODOLOGY; MICROBIOLOGY; NURSE PATIENT RELATIONSHIP; NURSING; PATIENT EDUCATION; PERITONEAL DIALYSIS; PERITONITIS; PROGNOSIS; RISK ASSESSMENT; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; CATHETER-RELATED INFECTIONS; FEMALE; FUNGEMIA; GENTAMICINS; HUMANS; MALE; MUPIROCIN; NURSE-PATIENT RELATIONS; PATIENT EDUCATION AS TOPIC; PERITONEAL DIALYSIS; PERITONITIS; PROGNOSIS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84880671131     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/sdi.12114     Document Type: Article

References (78)

1. Daly CD, Campbell MK, MacLeod AM, Cody DJ, Vale LD, Grant AM, Donaldson C, Wallace SA, Lawrence PD, Khan IH: Do the Y-set and double-bag systems reduce the incidence of CAPD peritonitis? A systematic review of randomized controlled trials. Nephrol Dial Transplant 16:341-347, 2001
2. Brown MC, Simpson K, Kerssens JJ, Mactier RA: Peritoneal dialysis-associated peritonitis rates and outcomes in a national cohort are not improving in the post-millennium (2000-2007). Perit Dial Int 31:639-650, 2011
3. Piraino B, Bernardini J, Brown E, Figueiredo A, Johnson DW, Lye WC, Price V, Ramalakshmi S, Szeto CC: ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int 31:614-630, 2011
4. Nessim SJ: Prevention of peritoneal dialysis-related infections. Semin Nephrol 31:199-212, 2011
5. Chow KM, Szeto CC, Leung CB, Law MC, Li PK: Impact of social factors on patients on peritoneal dialysis. Nephrol Dial Transplant 20:2504-2510, 2005
6. Martin LC, Caramori JC, Fernandes N, Divino-Filho JC, Pecoits-Filho R, Barretti P: Geographic and educational factors and risk of the first peritonitis episode in Brazilian Peritoneal Dialysis study (BRAZPD) patients. Clin J Am Soc Nephrol 6:1944-1951, 2011
7. Chow KM, Szeto CC, Law MC, Fun Fung JS, Kam-Tao Li P: Influence of peritoneal dialysis training nurses' experience on peritonitis rates. Clin J Am Soc Nephrol 2:647-652, 2007
8. Yang Z, Xu R, Zhuo M, Dong J: Advanced nursing experience is beneficial for lowering the peritonitis rate in patients on peritoneal dialysis. Perit Dial Int 32:60-66, 2012
9. Russo R, Manili L, Tiraboschi G, Amar K, De Luca M, Alberghini E, Ghiringhelli P, De Vecchi A, Porri MT, Marinangeli G, Rocca R, Paris V, Ballerini L: Patient re-training in peritoneal dialysis: why and when it is needed. Kidney Int 103:S127-132, 2006
10. Dong J, Chen Y: Impact of the bag exchange procedure on risk of peritonitis. Perit Dial Int 30:440-447, 2010
11. Mawar S, Gupta S, Mahajan S: Non-compliance to the continuous ambulatory peritoneal dialysis procedure increases the risk of peritonitis. Int Urol Nephrol 44:1243-1249, 2012
12. Figueiredo AE, Poli de Figueiredo CE, d'Avila DO: Peritonitis prevention in CAPD: to mask or not? Perit Dial Int 20:354-358, 2000
13. Firanek C, Guest S: Hand hygiene in peritoneal dialysis. Perit Dial Int 31:399-408, 2011
14. Miller TE, Findon G: Touch contamination of connection devices in peritoneal dialysis-a quantitative microbiologic analysis. Perit Dial Int 17:560-567, 1997
15. Rupp ME, Fitzgerald T, Puumala S, Anderson JR, Craig R, Iwen PC, Jourdan D, Keuchel J, Marion N, Peterson D, Sholtz L, Smith V: Prospective, controlled, cross-over trial of alcohol-based hand gel in critical care units. Infect Control Hosp Epidemiol 29:8-15, 2008
16. Gadola L, Poggi C, Poggio M, Saez L, Ferrari A, Romero J, Fumero S, Ghelfi G, Chifflet L, Borges PL: Using a multidisciplinary training program to reduce peritonitis in peritoneal dialysis patients. Perit Dial Int 33:38-45, 2013
17. Bordin G, Casati M, Sicolo N, Zuccherato N, Eduati V: Patient education in peritoneal dialysis: an observational study in Italy. J Renal Care 33:165-171, 2007
18. Oreopoulos DG, Bairdhelfrich G, Khanna R, Lum GM, Matthews R, Paulsen K, Twardowski ZJ, Vas SI: Peritoneal catheters and exit-site practices - current recommendations. Periton Dialysis Bull 7:130-138, 1987
19. Bennettjones DN, Martin J, Barratt AJ, Duffy TJ, Naish PF, Aber GM: Prophylactic gentamicin prevents early exit-site infections and peritonitis in CAPD. Periton Dialysis Int 8:66-66, 1988
20. Lye WC, Lee EJ, Tan CC: Prophylactic antibiotics in the insertion of Tenckhoff catheters. Scand J Urol Nephrol 26:177-180, 1992
21. Wikdahl AM, Engman U, Stegmayr BG, Sorenssen JG: One-dose cefuroxime i.v. and i.p. reduces microbial growth in PD patients after catheter insertion. Nephrol Dial Transplant 12:157-160, 1997
22. Gadallah MF, Ramdeen G, Mignone J, Patel D, Mitchell L, Tatro S: Role of preoperative antibiotic prophylaxis in preventing postoperative peritonitis in newly placed peritoneal dialysis catheters. Am J Kid Dis 36:1014-1019, 2000
23. Figueiredo A, Goh BL, Jenkins S, Johnson DW, Mactier R, Ramalakshmi S, Shrestha B, Struijk D, Wilkie M: Clinical practice guidelines for peritoneal access. Perit Dial Int 30:424-429, 2010
24. Piraino B, Bernardini J, Sorkin M: The influence of peritoneal catheter exit-site infections on peritonitis, tunnel infections, and catheter loss in patients on continuous ambulatory peritoneal dialysis. Am J Kid Dis 8:436-440, 1986
25. Davies SJ, Ogg CS, Cameron JS, Poston S, Noble WC: Staphylococcus aureus nasal carriage, exit-site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 9:61-64, 1989
26. Luzar MA, Coles GA, Faller B, Slingeneyer A, Dah GD, Briat C, Wone C, Knefati Y, Kessler M, Peluso F: Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med 322:505-509, 1990
27. Swartz R, Messana J, Starmann B, Weber M, Reynolds J: Preventing Staphylococcus aureus infection during chronic peritoneal dialysis. J Am Soc Nephrol 2:1085-1091, 1991
28. Amato D, de Jesus Ventura M, Miranda G, Leanos B, Alcantara G, Hurtado ME, Paniagua R: Staphylococcal peritonitis in continuous ambulatory peritoneal dialysis: colonization with identical strains at exit site, nose, and hands. Am J Kid Dis 37:43-48, 2001
29. van Diepen AT, Tomlinson GA, Jassal SV: The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients. Clin J Am Soc Nephrol 7:1266-1271, 2012
30. Piraino B, Bernardini J, Bender FH: An analysis of methods to prevent peritoneal dialysis catheter infections. Perit Dial Int 28:437-443, 2008
31. Strippoli GF, Tong A, Johnson D, Schena FP, Craig JC: Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. Am J Kid Dis 44:591-603, 2004
32. Tacconelli E, Carmeli Y, Aizer A, Ferreira G, Foreman MG, D'Agata EM: Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis 37:1629-1638, 2003
33. Xu G, Tu W, Xu C: Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis. Nephrol Dial Transplant 25:587-592, 2010
34. Mupirocin Study Group: Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. J Am Soc Nephrol 7:2403-2408, 1996
35. Bernardini J, Bender F, Florio T, Sloand J, Palmmontalbano L, Fried L, Piraino B: Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 16:539-545, 2005
36. Bernardini J, Piraino B, Holley J, Johnston JR, Lutes R: A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am J Kid Dis 27:695-700, 1996
37. Chu KH, Choy WY, Cheung CC, Fung KS, Tang HL, Lee W, Cheuk A, Yim KF, Chan WH, Tong KL: A prospective study of the efficacy of local application of gentamicin versus mupirocin in the prevention of peritoneal dialysis catheter-related infections. Perit Dial Int 28:505-508, 2008
38. Davenport A: Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit. J Nephrol 25:819-824, 2012
39. Lim CT, Wong KS, Foo MW: The impact of topical mupirocin on peritoneal dialysis infection in Singapore General Hospital. Nephrol Dial Transplant 20:2202-2206, 2005
40. Luzar MA, Brown CB, Balf D, Hill L, Issad B, Monnier B, Moulart J, Sabatier JC, Wauquier JP, Peluso F: Exit-site care and exit-site infection in continuous ambulatory peritoneal dialysis (CAPD): results of a randomized multicenter trial. Perit Dial Int 10:25-29, 1990
41. Mahajan S, Tiwari SC, Kalra V, Bhowmik DM, Agarwal SK, Dash SC, Kumar P: Effect of local mupirocin application on exit-site infection and peritonitis in an Indian peritoneal dialysis population. Perit Dial Int 25:473-477, 2005
42. McQuillan RF, Chiu E, Nessim S, Lok CE, Roscoe JM, Tam P, Jassal SV: A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study. Clin J Am Soc Nephrol 7:297-303, 2012
43. Pierce DA, Williamson JC, Mauck VS, Russell GB, Palavecino E, Burkart JM: The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis. Perit Dial Int 32:525-530, 2012
44. Piraino B, Bernardini J, Florio T, Fried L: Staphylococcus aureus prophylaxis and trends in gram-negative infections in peritoneal dialysis patients. Perit Dial Int 23:456-459, 2003
45. Wong SS, Chu KH, Cheuk A, Tsang WK, Fung SK, Chan HW, Tong MK: Prophylaxis against gram-positive organisms causing exit-site infection and peritonitis in continuous ambulatory peritoneal dialysis patients by applying mupirocin ointment at the catheter exit site. Perit Dial Int 23(Suppl 2):S153-158, 2003
46. Annigeri R, Conly J, Vas S, Dedier H, Prakashan KP, Bargman JM, Jassal V, Oreopoulos D: Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int 21:554-559, 2001
47. Boelaert JR, De Smedt RA, De Baere YA, Godard CA, Matthys EG, Schurgers ML, Daneels RF, Gordts BZ, Van Landuyt HW: The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients. Nephrol Dial Transplant 4:278-281, 1989
48. Cookson BD: The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J Antimicrob Chemother 41:11-18, 1998
49. Miller MA, Dascal A, Portnoy J, Mendelson J: Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 17:811-813, 1996
50. Upton A, Lang S, Heffernan H: Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance. J Antimicrob Chemother 51:613-617, 2003
51. Vasquez JE, Walker ES, Franzus BW, Overbay BK, Reagan DR, Sarubbi FA: The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a Veterans' Affairs hospital. Infect Control Hosp Epidemiol 21:459-464, 2000
52. Zakrzewska-Bode A, Muytjens HL, Liem KD, Hoogkamp-Korstanje JA: Mupirocin resistance in coagulase-negative staphylococci, after topical prophylaxis for the reduction of colonization of central venous catheters. J Hosp Infect 31:189-193, 1995
53. Perez-Fontan M, Rosales M, Rodriguez-Carmona A, Falcon TG, Valdes F: Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kid Dis 39:337-341, 2002
54. Lobbedez T, Gardam M, Dedier H, Burdzy D, Chu M, Izatt S, Bargman JM, Jassal SV, Vas S, Brunton J, Oreopoulos DG: Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years. Nephrol Dial Transplant 19:3140-3143, 2004
55. Cho Y, Badve SV, Hawley CM, McDonald SP, Brown FG, Boudville N, Wiggins KJ, Bannister KM, Clayton P, Johnson DW: Effects of climatic region on peritonitis risk, microbiology, treatment, and outcomes: a multicenter registry study. Perit Dial Int 33:75-85, 2013
56. Goldie SJ, Kiernan-Tridle L, Torres C, Gorban-Brennan N, Dunne D, Kliger AS, Finkelstein FO: Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. Am J Kid Dis 28:86-91, 1996
57. Matuszkiewicz-Rowinska J: Update on fungal peritonitis and its treatment. Perit Dial Int 29(Suppl 2):S161-165, 2009
58. Miles R, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW: Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int 76:622-628, 2009
59. Robitaille P, Merouani A, Clermont MJ, Hebert E: Successful antifungal prophylaxis in chronic peritoneal dialysis: a pediatric experience. Perit Dial Int 15:77-79, 1995
60. Thodis E, Vas SI, Bargman JM, Singhal M, Chu M, Oreopoulos DG: Nystatin prophylaxis: its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 18:583-589, 1998
61. Wong PN, Lo KY, Tong GM, Chan SF, Lo MW, Mak SK, Wong AK: Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD. Perit Dial Int 27:531-536, 2007
62. Zaruba K, Peters J, Jungbluth H: Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: six years' experience. Am J Kid Dis 17:43-46, 1991
63. Williams PF, Moncrieff N, Marriott J: No benefit in using nystatin prophylaxis against fungal peritonitis in peritoneal dialysis patients. Perit Dial Int 20:352-353, 2000
64. Lo WK, Chan CY, Cheng SW, Poon JF, Chan DT, Cheng IK: A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kid Dis 28:549-552, 1996
65. Restrepo C, Chacon J, Manjarres G: Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial. Perit Dial Int 30:619-625, 2010
66. Su CY, Pei J, Lu XH, Tang W, Wang T: Gastrointestinal symptoms predict peritonitis rates in CAPD patients. Clin Nephrol 77:267-274, 2012
67. Wood CJ, Fleming V, Turnidge J, Thomson N, Atkins RC: Campylobacter peritonitis in continuous ambulatory peritoneal dialysis: report of eight cases and a review of the literature. Am J Kid Dis 19:257-263, 1992
68. Schweinburg FB, Seligman AM, Fine J: Transmural migration of intestinal bacteria; a study based on the use of radioactive Escherichia coli. N Engl J Med 242:747-751, 1950
69. Singharetnam W, Holley JL: Acute treatment of constipation may lead to transmural migration of bacteria resulting in gram-negative, polymicrobial, or fungal peritonitis. Perit Dial Int 16:423-425, 1996
70. Chuang YW, Shu KH, Yu TM, Cheng CH, Chen CH: Hypokalaemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients. Nephrol Dial Transplant 24:1603-1608, 2009
71. Yip T, Tse KC, Lam MF, Cheng SW, Lui SL, Tang S, Ng M, Chan TM, Lai KN, Lo WK: Colonic diverticulosis as a risk factor for peritonitis in Chinese peritoneal dialysis patients. Perit Dial Int 30:187-191, 2010
72. Yip T, Tse KC, Lam MF, Cheng SW, Lui SL, Tang S, Ng M, Chan TM, Lai KN, Lo WK: Risks and outcomes of peritonitis after flexible colonoscopy in CAPD patients. Perit Dial Int 27:560-564, 2007
73. Yap DY, Tse KC, Lam MF, Chan TM, Lai KN: Polymicrobial CAPD peritonitis after hysteroscopy. Perit Dial Int 29:237-238, 2009
74. Morimoto S, Kido E, Higashi M, Sumitani N, Takagishi H, Kakimoto S, Someya K, Morita T, Iwasaka T, Suzuki K, Yasui A: Peritonitis after gynecological and gastroscopic examinations in a peritoneal dialysis patient. Clin Nephrol 74:491-492, 2010
75. Li PK, Leung CB, Leung AK, Luk WK, Lai KN: Posthysteroscopy fungal peritonitis in a patient on continuous ambulatory peritoneal dialysis. Am J Kid Dis 21:446-448, 1993
76. Lockhart PB, Brennan MT, Sasser HC, Fox PC, Paster BJ, Bahrani-Mougeot FK: Bacteremia associated with toothbrushing and dental extraction. Circulation 117:3118-3125, 2008
77. Fried L, Bernardini J, Piraino B: Iatrogenic peritonitis: the need for prophylaxis. Perit Dial Int 20:343-345, 2000
78. Kiddy K, Brown PP, Michael J, Adu D: Peritonitis due to Streptococcus viridans in patients receiving continuous ambulatory peritoneal dialysis. Brit Med J 290:969-970, 1985